<abstract xmlns="http://www.w3.org/1999/xhtml"><sec id="j_raon-2020-0074_s_005_w2aab3b7c72b1b6b1aab1c15b1Aa"><h3>Background</h3><p>Radiotherapy-associated angiosarcoma (RAA) of the breast is a rare complication of radiotherapy, which is often difficult to identify and has poor prognosis. It usually presents as violaceous skin, erythema or rapidly growing palpable firm mass that can be confused with other benign skin lesions.</p></sec><sec id="j_raon-2020-0074_s_006_w2aab3b7c72b1b6b1aab1c15b2Aa"><h3>Patients and methods</h3><p>After reviewing the literature, we found only four cases with RAA after mastectomy and autologous breast reconstruction. The presented case is the first that was treated by electrochemotherapy. The patient presented with secondary angiosarcoma of the breast five years after mastectomy, immediate breast reconstruction with deep inferior epigastric artery perforator free flap and adjuvant radiotherapy.</p></sec><sec id="j_raon-2020-0074_s_007_w2aab3b7c72b1b6b1aab1c15b3Aa"><h3>Results</h3><p>Electrochemotherapy was feasible, safe and effective in treatment of radiation induced sarcoma. Most of the treated lesions in several consecutive electrochemotherapy sessions responded with complete response, but multiple recurrences occurred in non-treated areas.</p></sec><sec id="j_raon-2020-0074_s_008_w2aab3b7c72b1b6b1aab1c15b4Aa"><h3>Conclusions</h3><p>Patients with breast cancer after skin-sparing mastectomy and immediate breast reconstruction, who receive radiotherapy, need regular long-term follow up and low threshold for biopsy of any suspicious lesions is mandatory. Electrochemotherapy proved as one of feasible modalities of treatment for RAA.</p></sec></abstract>

BackgroundRadiotherapy-associated angiosarcoma (RAA) of the breast is a rare complication of radiotherapy, which is often difficult to identify and has poor prognosis. It usually presents as violaceous skin, erythema or rapidly growing palpable firm mass that can be confused with other benign skin lesions.Patients and methodsAfter reviewing the literature, we found only four cases with RAA after mastectomy and autologous breast reconstruction. The presented case is the first that was treated by electrochemotherapy. The patient presented with secondary angiosarcoma of the breast five years after mastectomy, immediate breast reconstruction with deep inferior epigastric artery perforator free flap and adjuvant radiotherapy.ResultsElectrochemotherapy was feasible, safe and effective in treatment of radiation induced sarcoma. Most of the treated lesions in several consecutive electrochemotherapy sessions responded with complete response, but multiple recurrences occurred in non-treated areas.ConclusionsPatients with breast cancer after skin-sparing mastectomy and immediate breast reconstruction, who receive radiotherapy, need regular long-term follow up and low threshold for biopsy of any suspicious lesions is mandatory. Electrochemotherapy proved as one of feasible modalities of treatment for RAA.


<div xmlns="http://www.w3.org/1999/xhtml"><sec id="j_raon-2020-0074_s_001_w2aab3b7c72b1b6b1ab1aAa"><div>Introduction</div><p>Angiosarcoma of the breast is a rare malignancy, which can occur as primary without a known precursor or as secondary from associated radiotherapy or chronic lymphedema.<a ref-type="bibr" href="#j_raon-2020-0074_ref_001_w2aab3b7c72b1b6b1ab2b1b1Aa">1</a> Although radiotherapy-associated angiosarcoma (RAA) is a rare complication of radiotherapy, it is the most frequent classifiable sarcoma arising in women with breast cancer treated with radiotherapy in the field of irradiated soft tissue.<a ref-type="bibr" href="#j_raon-2020-0074_ref_002_w2aab3b7c72b1b6b1ab2b1b2Aa">2</a> The diagnosis is usually late because initial signs of RAA may be subtle and difficult to identify. Cahn <italic>et al</italic>. suggested the following criteria for the diagnosis of RAA: the sarcoma should arise in the area previously subjected to irradiation, a latent period (in years) must exist between the time of irradiation and development of the sarcoma, and the sarcoma must be confirmed histologically.<a ref-type="bibr" href="#j_raon-2020-0074_ref_003_w2aab3b7c72b1b6b1ab2b1b3Aa">3</a></p><p>Radiotherapy continues to be a mainstay modality in the treatment of breast cancer patients after breast conserving surgery and has a significant role in preventing local recurrence of breast tumors.<a ref-type="bibr" href="#j_raon-2020-0074_ref_001_w2aab3b7c72b1b6b1ab2b1b1Aa">1</a> After reviewing the literature, we found most of the cases with RAA after breast conserving surgery and only four cases with RAA after mastectomy and autologous breast reconstruction.<a ref-type="bibr" href="#j_raon-2020-0074_ref_004_w2aab3b7c72b1b6b1ab2b1b4Aa">4</a>, <a ref-type="bibr" href="#j_raon-2020-0074_ref_005_w2aab3b7c72b1b6b1ab2b1b5Aa">5</a>, <a ref-type="bibr" href="#j_raon-2020-0074_ref_006_w2aab3b7c72b1b6b1ab2b1b6Aa">6</a> We report a case of RAA after bilateral skin-sparing mastectomy and immediate free flap breast reconstruction to highlight awareness of the disease in an autologous breast reconstruction and the importance of early detection. Furthermore, we want to show that electrochemotherapy, might be applied even in such a rare condition in the palliative intent.<a ref-type="bibr" href="#j_raon-2020-0074_ref_007_w2aab3b7c72b1b6b1ab2b1b7Aa">7</a></p></sec><sec id="j_raon-2020-0074_s_002_w2aab3b7c72b1b6b1ab1b1Aa"><div>Case report and literature review</div><p>A 63-year-old Caucasian female presented with central violaceous or hyperpigmented macule surrounded by an erythematous ring in the lower inner quadrant of her right breast measuring 3 x 5 cm (<a ref-type="fig" href="#j_raon-2020-0074_fig_001_w2aab3b7c72b1b6b1ab1b1b2Aa">Figure 1</a>) in June 2016. She had a history of synchronous bilateral hormone positive HER-2 positive breast carcinoma with positive lymph nodes in the right axilla six years ago. After six cycles of the neoadjuvant 5-Fluoro uracil, epirubicin and cyclophosphamide (FEC-100) chemotherapy bilateral skin-sparing mastectomy, axillary lymph node dissection on the right and sentinel node biopsy on the left side followed, and immediate bilateral breast reconstruction with deep inferior epigastric perforator (DIEP) flap was performed in April 2010.</p><figure id="j_raon-2020-0074_fig_001_w2aab3b7c72b1b6b1ab1b1b2Aa" position="float" fig-type="figure"><h2>Figure 1</h2><figCaption><p>Clinical presentation of patient with angiosarcoma of right reconstructed breast.</p></figCaption><img xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="graphic/j_raon-2020-0074_fig_001.jpg" src="https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647355e34e662f30ba53aa6c/j_raon-2020-0074_fig_001.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20240717T160633Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Expires=18000&amp;X-Amz-Credential=AKIA6AP2G7AKP25APDM2%2F20240717%2Feu-central-1%2Fs3%2Faws4_request&amp;X-Amz-Signature=cd84e10c7335acb29e7d040d415a839aed27f2778b0c429aa4f69b2207917259" class="mw-100"/></figure><p>Histology showed pathologic complete response of the tumor in the breast, with less than 10% of tumor cells and complete response in the right axilla. Postoperative irradiation of the right mammary region was done with 25 Gy in 2 Gy fractions followed by adjuvant hormonal treatment with letrozole for five years and later extended adjuvant hormonal therapy with tamoxifen.</p><p>She had regular follow up and was doing well until the lesion in her right breast was presented in October 2015. First, it was treated as fungal infection with topical ointments and later with corticosteroid ointments. Eight months after the first presentation, fine needle aspiration biopsy was done and suggested a melanocytic lesion, possible melanoma. In June 2016, excision of the lesion was performed and pathological examination revealed RAA, high grade, multinodular, involving dermis and free flap, infiltrating lateral resection margins (<a ref-type="fig" href="#j_raon-2020-0074_fig_002_w2aab3b7c72b1b6b1ab1b1b5Aa">Figure 2</a>). Amplification of the MYC oncogene was confirmed using fluorescence in situ hybridization (FISH) method (<a ref-type="fig" href="#j_raon-2020-0074_fig_003_w2aab3b7c72b1b6b1ab1b1b6Aa">Figure 3</a>). Patient underwent six cycles of chemotherapy with paclitaxel followed by wide resection of the affected area in January 2017. Pathological examination revealed multifocal residual angiosarcoma in area of 10 cm in diameter, involving skin and subcutaneous tissue with at least 1 cm clear resection margins. Four months after the last operation, in May 2017, she developed second local recurrence with multiple small skin lesion around the scar of the right breast. She received second-line chemotherapy with liposomal doxorubicin with stagnation of the lesions.</p><figure id="j_raon-2020-0074_fig_002_w2aab3b7c72b1b6b1ab1b1b5Aa" position="float" fig-type="figure"><h2>Figure 2</h2><figCaption><p>Pathologic hematoxylin and eosin (HE) specimen showing radiotherapy-associated angiosarcoma (RAA) involving dermis.</p></figCaption><img xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="graphic/j_raon-2020-0074_fig_002.jpg" src="https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647355e34e662f30ba53aa6c/j_raon-2020-0074_fig_002.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20240717T160633Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Expires=18000&amp;X-Amz-Credential=AKIA6AP2G7AKP25APDM2%2F20240717%2Feu-central-1%2Fs3%2Faws4_request&amp;X-Amz-Signature=f85181af6cb4453dcdf391e360e00c00c7d68b9f6000ae563f7f6b5c45dfca08" class="mw-100"/></figure><figure id="j_raon-2020-0074_fig_003_w2aab3b7c72b1b6b1ab1b1b6Aa" position="float" fig-type="figure"><h2>Figure 3</h2><figCaption><p>Amplification of the MYC oncogene was confirmed using FISH method on tumor specimen.</p></figCaption><img xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="graphic/j_raon-2020-0074_fig_003.jpg" src="https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647355e34e662f30ba53aa6c/j_raon-2020-0074_fig_003.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20240717T160633Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Expires=18000&amp;X-Amz-Credential=AKIA6AP2G7AKP25APDM2%2F20240717%2Feu-central-1%2Fs3%2Faws4_request&amp;X-Amz-Signature=8435811cc54c0d0ce6b4eabcf85bd278d1894a1e7c6a8e6b607e42d336c90b77" class="mw-100"/></figure><p>In October 2017 resection of the largest skin lesion in combination with electrochemotherapy (ECT) of the smaller 6 skin lesions (indicated in <a ref-type="fig" href="#j_raon-2020-0074_fig_004_w2aab3b7c72b1b6b1ab1b1b8Aa">Figure 4</a>), with diameter 0.8–1.2 cm and thickness 0.2–0.4 cm, was performed (<a ref-type="fig" href="#j_raon-2020-0074_fig_004_w2aab3b7c72b1b6b1ab1b1b8Aa">Figure 4</a>). ECT was performed 8 minutes after i.v. bleomycin infusion (30,000 IU) lasting 2 minutes using hexagonal electrodes and Cliniporator electric pulse generator (IGEA, s.r.l., Carpi, Italy) according to the SOP.<a ref-type="bibr" href="#j_raon-2020-0074_ref_008_w2aab3b7c72b1b6b1ab2b1b8Aa">8</a>, <a ref-type="bibr" href="#j_raon-2020-0074_ref_009_w2aab3b7c72b1b6b1ab2b1b9Aa">9</a> Trains of 8 electric pulses (1000 V/cm), each pulse 100 μs long, were delivered to each pair of electrodes consecutively. Altogether 7 electric pulse applications were performed. The patient had complete regression of the area treated 1 month after ECT. In December 2017, two months after the ECT treatment there was a third recurrence outside of the treated area. While other lesions were in complete regression also 2 months after ECT one of the treated lesions recurred. Fine needle biopsy of new and recurred lesion confirmed angiosarcoma metastases. Therefore, additional ECT was performed in January 2018 on 7 lesions, resulting in partial response of 1 lesion, stable disease of 1 lesion and complete response of other 5 lesions, 2 months after the treatment. Treatment was performed in the same way as in the first ECT session. Nevertheless, several new lesions occurred. The lesions were approximately 0.4 cm in diameter and scattered throughout the chest. Although the edema was present at several parts of the chest skin, ECT was performed once again in order to palliate the symptoms in March 2018. Plate electrodes were used to treat 40 small nodules. At next follow up, 1 month after the third ECT session all treated nodules regressed (most of them were in complete response and some of them in partial response). As already observed, new recurrences occurred in an interval less than one month after the last ECT and she received third line of chemotherapy with gemcitabine in May 2018. She received also four lines of target therapy, but despite our best effort she died as a consequence of local tumor progression in May 2019, nearly 36 months after RAA presentation.</p><figure id="j_raon-2020-0074_fig_004_w2aab3b7c72b1b6b1ab1b1b8Aa" position="float" fig-type="figure"><h2>Figure 4</h2><figCaption><p>Treatment with electrochemotherapy. <bold>(A)</bold> Just before the treatment nodules were marked for evaluation; <bold>(B)</bold> 1 month after the treatment all nodules were in complete response.</p></figCaption><img xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="graphic/j_raon-2020-0074_fig_004.jpg" src="https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647355e34e662f30ba53aa6c/j_raon-2020-0074_fig_004.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20240717T160633Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Expires=18000&amp;X-Amz-Credential=AKIA6AP2G7AKP25APDM2%2F20240717%2Feu-central-1%2Fs3%2Faws4_request&amp;X-Amz-Signature=479bc20daa683d4ec79881ddc81d057d3c21a236f743dcd09f67bc56eff5f594" class="mw-100"/></figure><p>While the development of secondary angiosarcoma due to radiation is not uncommon in patients who underwent lumpectomy, the development of RAA in reconstructed breast is extremely rare with only four other cases reported in the literature.<a ref-type="bibr" href="#j_raon-2020-0074_ref_004_w2aab3b7c72b1b6b1ab2b1b4Aa">4</a>, <a ref-type="bibr" href="#j_raon-2020-0074_ref_005_w2aab3b7c72b1b6b1ab2b1b5Aa">5</a>, <a ref-type="bibr" href="#j_raon-2020-0074_ref_006_w2aab3b7c72b1b6b1ab2b1b6Aa">6</a> In all four cases, RAA developed after more than 5 years after radiotherapy. In three cases modified radical mastectomy was done. In all cases the type of reconstruction was autologous - free transverse rectus abdominis muscle (TRAM), free deep inferior epigastric artery perforator (DIEP) flap as in our case and one case of a pedicled flap. In all reported cases, surgery was the most important, and in all but one, the only treatment modality. <a ref-type="table" href="#j_raon-2020-0074_tab_001_w2aab3b7c72b1b6b1ab1b1c10Aa">Table 1</a> represents the summary of case reports with RAA in the reconstructed breast.</p><table-wrap id="j_raon-2020-0074_tab_001_w2aab3b7c72b1b6b1ab1b1c10Aa" position="float"><label>Table 1</label><caption><p>Case reports with radiotherapy-associated angiosarcoma (RAA) after autologous breast reconstruction</p></caption><table rules="groups"><thead><tr><th align="left">First author</th><th align="left">Year published</th><th align="left">Case #</th><th align="left">Years after RT</th><th align="left">Type of cancer surgery</th><th align="left">Type of breast reconstruction</th></tr></thead><tbody><tr><td align="left">Hanasono <italic>et al</italic>.<a ref-type="bibr" href="#j_raon-2020-0074_ref_004_w2aab3b7c72b1b6b1ab2b1b4Aa">4</a></td><td align="left">2005</td><td align="left">1</td><td align="left">6</td><td align="left">mastectomy</td><td align="left">DIEP flap</td></tr><tr><td align="left">Aljarrah <italic>et al</italic>.<a ref-type="bibr" href="#j_raon-2020-0074_ref_005_w2aab3b7c72b1b6b1ab2b1b5Aa">5</a></td><td align="left">2014</td><td align="left">2</td><td align="left">6</td><td align="left">mastectomy</td><td align="left">TRAM flap</td></tr><tr><td align="left">Yip <italic>et al</italic>.<a ref-type="bibr" href="#j_raon-2020-0074_ref_006_w2aab3b7c72b1b6b1ab2b1b6Aa">6</a></td><td align="left">2019</td><td align="left">3</td><td align="left">5</td><td align="left">mastectomy and axillary lymph node dissection</td><td align="left">LD flap</td></tr><tr><td align="left">Yip <italic>et al</italic>.<a ref-type="bibr" href="#j_raon-2020-0074_ref_006_w2aab3b7c72b1b6b1ab2b1b6Aa">6</a></td><td align="left">2019</td><td align="left">4</td><td align="left">10</td><td align="left">mastectomy and axillary lymph node dissection</td><td align="left">DIEP flap</td></tr></tbody></table><table-wrap-foot><fn-group><fn id="j_raon-2020-0074_tfn_001_w2aab3b7c72b1b6b1ab1b1c10b3aaAa"><p>DIEP = deep inferior epigastric artery perforator; MRM = modified radical mastectomy; RT = radiotherapy; TRAM = transverse rectus abdominis muscle; LD = latissimus dorsi muscle</p></fn></fn-group></table-wrap-foot></table-wrap></sec><sec id="j_raon-2020-0074_s_003_w2aab3b7c72b1b6b1ab1b2Aa"><div>Discussion</div><p>Radiotherapy plays an important role for many patients diagnosed with breast cancer to reduce local recurrence after breast-conserving surgery, rarely after mastectomy in specific cases. However, it is associated with increased risk of developing a secondary cancer, including tumors of the skin, such as basal cell carcinoma, squamous cell carcinoma, melanoma and angiosarcoma.<a ref-type="bibr" href="#j_raon-2020-0074_ref_010_w2aab3b7c72b1b6b1ab2b1c10Aa">10</a></p><p>Radiation-associated angiosarcoma of the breast often appears as violaceous skin, erythema, palpable firm mass, skin thickening or skin dimpling, papules and edema that can be confused with other benign skin lesions, such as telangiectasia or changes associated with trauma.<a ref-type="bibr" href="#j_raon-2020-0074_ref_001_w2aab3b7c72b1b6b1ab2b1b1Aa">1</a>, <a ref-type="bibr" href="#j_raon-2020-0074_ref_011_w2aab3b7c72b1b6b1ab2b1c11Aa">11</a> Atypical post-radiation vascular proliferation (APRVP) is one of vascular radiation-associated lesion that shares similar clinical and histologic features to RAA. The vast majority of APRVP has benign clinical course, although coexistence of APRVP and RAA has been described in some reports and raises the possibility that APRVP represents a precursor of RAA although this theory remains controversial.<a ref-type="bibr" href="#j_raon-2020-0074_ref_012_w2aab3b7c72b1b6b1ab2b1c12Aa">12</a> Immunohistochemical staining and FISH method for MYC are helpful in distinguishing benign and atypical vascular lesions from RAA since amplification of MYC is present in more than 90% of secondary angiosarcomas and is absent in atypical vascular lesions.<a ref-type="bibr" href="#j_raon-2020-0074_ref_001_w2aab3b7c72b1b6b1ab2b1b1Aa">1</a> Subtle clinical signs and rare occurrence of the disease often delay the diagnosis as in our case, so the diagnosis of atypical vascular lesions in violaceous or erythematous skin in irradiated breast should prompt further investigation to rule out RAA. Excision biopsy and pathological examination is necessary for definitive diagnosis.</p><p>Angiosarcoma of the breast can develop as primary or secondary malignancy. The distinction between primary breast angiosarcoma and secondary RAA is that the former arises within the mammary parenchyma, whereas the latter is principally a dermal/subcutaneous lesion that may or may not invade the underlying parenchyma and is usually multifocal.<a ref-type="bibr" href="#j_raon-2020-0074_ref_011_w2aab3b7c72b1b6b1ab2b1c11Aa">11</a>,<a ref-type="bibr" href="#j_raon-2020-0074_ref_013_w2aab3b7c72b1b6b1ab2b1c13Aa">13</a> In our case, the tumor invaded the dermis and also the parenchyma of the free flap. Partial fat necrosis, which usually presents as firm mass, with skin unchanged, is a known complication after breast reconstruction with DIEP flap and can misguide the diagnosis of RAA.<a ref-type="bibr" href="#j_raon-2020-0074_ref_014_w2aab3b7c72b1b6b1ab2b1c14Aa">14</a></p><p>Most of the RAA present as localized and multifocal disease. The median time from the administration of RT for primary breast cancer to the diagnosis of angiosarcoma ranges from four to 11 years, on average 7 years.<a ref-type="bibr" href="#j_raon-2020-0074_ref_015_w2aab3b7c72b1b6b1ab2b1c15Aa">15</a> The presented case and all four reported cases developed RAA five years or more after radiotherapy. Therefore, careful patient evaluation for early disease detection in long-term follow up of patients that received radiotherapy even in cases of autologous breast reconstruction for breast cancer is needed.</p><p>Optimal management of angiosarcoma has not yet been defined. The primary treatment remains wide resection of the tumor with negative margins. The retrospective national Finish study observed a greater number of local recurrences in patients when there were less than 1 cm tumor free margins and concluded that management of RAA of the breast currently involves a radical excision of the irradiated breast area.<a ref-type="bibr" href="#j_raon-2020-0074_ref_016_w2aab3b7c72b1b6b1ab2b1c16Aa">16</a> The role of adjuvant and neoadjuvant chemotherapy remains uncertain. Our case and case reported by Aljarrah <italic>et al</italic>.<a ref-type="bibr" href="#j_raon-2020-0074_ref_005_w2aab3b7c72b1b6b1ab2b1b5Aa">5</a> were the only two cases that used adjuvant chemotherapy after radical surgery. In three out of five reported cases surgery was the main and only treatment modality. Lately ECT joined as feasible therapy as there was reported 80% of objective response rate in 20 patients with advanced angiosarcoma that were treated with the use of ECT.<a ref-type="bibr" href="#j_raon-2020-0074_ref_017_w2aab3b7c72b1b6b1ab2b1c17Aa">17</a> In our case, ECT resulted in a complete response in the treated area but new tumors developed outside of the treated area in less than 2 months. Multimodal therapy seems promising in achieving longer survival as in our case, where the patient lived for almost 3 years after the initial diagnosis of RAA. In all other reported cases the follow up was up to one year or it was not defined, therefore we do not know if they had any recurrences after that time.</p></sec><sec id="j_raon-2020-0074_s_004_w2aab3b7c72b1b6b1ab1b3Aa"><div>Conclusions</div><p>Women with breast cancer after skin-sparing mastectomy and immediate breast reconstruction rarely receive radiotherapy. Those who receive radiotherapy need regular long-term follow up and low threshold for biopsy of any suspicious lesions is mandatory. ECT proved as one of feasible modalities of treatment.</p></sec></div>

Radiotherapy-associated angiosarcoma in the breast reconstructed by autologous free-flap and treated with electrochemotherapy

Radiology and Oncology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

BackgroundRadiotherapy-associated angiosarcoma (RAA) of the breast is a rare complication of radiotherapy, which is often difficult to identify and has poor...

Radiotherapy-associated angiosarcoma in the breast reconstructed by autologous free-flap and treated with electrochemotherapy

Article Category: Research Article

Publié en ligne: 29 déc. 2020

Pages: 77 - 81

DOI: https://doi.org/10.2478/raon-2020-0074

© 2021 Romi Cencelj-Arnez, Jerica Novak, Andreja Klevisar Ivancic, Masa Bosnjak, Maja Cemazar, Marko Snoj, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.